KIRIKKALE nire...
YAHŞIHAN nire...
KONUTTA öyle bir HAKSIZ RANT şişirilmiş ki, DANDİK İLÇELERİN imar müdürleri bile, BODRUM'da VİLLALAR ve SPOR ARABALAR ile geziyor.
MERKEZİ İMAR KURUMU kurulmalıdır.
İMAR belediyelerin işi değildir.
https://t.co/5gM7rm95kO
KURBAN YARDIMI yaparken,
TÜRKİYE'deki her 3 ÇOCUKTAN 2'sinin,
TAVUK ETİ dahi yiyemediğini, aklınızdan çıkarmayın.
Lütfen, TÜRKİYE'de kestirin ve TÜRKİYE'de dağıtın.
@ArielBurakKapln Cezaevindeki suçlulara ve rehabilitasyon merkezlerindeki uyuşturucu bağımlılarına günde 3 öğün tatlısından salatsına kadar yemek ücretsiz.
Customer access should move at the same speed as innovation. When the healthcare industry works together to reach individuals, it does.
Since last week, thousands of people have signed up for our Wegovy® waitlist. Starting today, eligible Hims & Hers customers can start their journeys with @novonordisk’s FDA-approved Wegovy® Pill & Wegovy® Pen and partner with their provider on a comprehensive weight loss program designed to help them achieve their goals.
We take our role as the largest global consumer health platform seriously, and I can’t wait to keep finding ways to make sure everyone can access the tools they need to feel great.
Read more below from Dr. Craig, our Head of Weight Loss, on what’s available today. (And if you’re starting your Wegovy journey with us today, tag me and tell me how it’s going!)
More details, including important info, here: https://t.co/zBQXvwHnIt
A new era of weight management is coming to Hims & Hers.
Soon: access to FDA-approved GLP-1 treatments — including Wegovy® pills and injections.
Join our exclusive pre-launch waitlist today: https://t.co/vcRGmkazsE
𝘞𝘦𝘨𝘰𝘷𝘺® 𝘪𝘴 𝘢 𝘳𝘦𝘨𝘪𝘴𝘵𝘦𝘳𝘦𝘥 𝘵𝘳𝘢𝘥𝘦𝘮𝘢𝘳𝘬 𝘰𝘧 𝘕𝘰𝘷𝘰 𝘕𝘰𝘳𝘥𝘪𝘴𝘬 𝘈/𝘚.